Celltrion | 068270 - Ebitda


Celltrion reported KRW25.72B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -5.56M 4.13M Jun/2026
Celltrion KRW 25.72B 6.08B Jun/2026
Dianthus Therapeutics USD -61.38M 14.92M Jun/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Moderna USD -1.26B 468M Mar/2026
Organon & Co USD 502M 131M Sep/2026
Revvity USD 228.18M 44.73M Jun/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.19B 138.8M Jun/2026
Xeris Pharmaceuticals USD -20.94M 33.27M Jun/2026